TCOV
HAE icon

Trust Company of Vermont’s Haemonetics HAE Stock Holding History

Trust Company of Vermont’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-63
Closed -$3K – 800
2015
Q2 		$3K Buy
+63
New +$2.66K ﹤0.01% 764

Other funds holding HAE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Trust Company of Vermont's HAE Position: Q3 2015 in Review

Trust Company of Vermont sold out of Haemonetics (HAE) in Q3 2015, closing a stake of 63 shares — an estimated $3K sold.

Trust Company of Vermont first reported a position in HAE in Q2 2015 and held it in 1 quarter. The position peaked at $3K in Q2 2015. 172 funds tracked by Wall St. Rank hold HAE as of Q3 2015.

  • Trust Company of Vermont reported no remaining Haemonetics position as of Q3 2015 after selling out during the quarter.
  • Trust Company of Vermont sold 63 Haemonetics shares in Q3 2015, an estimated $3K.
  • Trust Company of Vermont first reported a position in Haemonetics in Q2 2015 and held it in 1 quarter.
  • Trust Company of Vermont's Haemonetics position peaked at $3K in Q2 2015.
  • 172 funds tracked by Wall St. Rank held Haemonetics as of Q3 2015.

Based on Trust Company of Vermont's 13F filing for Q3 2015, filed 29 Oct 2015.